PeptiGrowth Inc. (Headquarters: Chiyoda-ku, Tokyo; President: Jiro Sugimoto) has successfully developed a novel synthetic ...

Event: 2024 Cell & Gene Meeting on the Mesa Session Date and Time: October 7, 2024, at 5:45 p.m. MST Location: FLW Ballroom F For more information, please visit FibroBiologics' website or email ...

As people age, more patients are developing heart failure. A study from Nagoya University found that an enzyme called PKN is ...

Zhejiang Doer Biologics Co., Ltd. ('Doer Bio'), a clinical stage biopharmaceutical company developing innovative biotherapeutics for metabolic diseases and cancers, today announces that DR10624, its ...

DNA components extracted from the gonads of this fish, polynucleotides have the ability to increase the viability and number of fibroblasts, which are the cells responsible for the synthesis of ...

“While all dermatologists treat hair, skin and nails, finding someone who has special training and interest in skin of color ...

Pete O'Heeron, Founder and Chief Executive Officer of FibroBiologics, said, "This engagement is an important step forward in creating the infrastructure for FibroBiologics to conduct clinical trials ...

With less than 50 days until the US election, Anthony Zurcher looks at how the rate cut will shape the presidential campaign. It will influence mortgages, credit card and saving rates for millions ...

“Our ongoing exploration of therapeutic applications using fibroblast cells continues to provide unique opportunities for our platform,” commented founder & CEO of FibroBiologics, Pete O’Heeron. “This ...

The enzyme catalyzes the conversion of heart fibroblasts to myofibroblasts, which threatens the integrity of the heart. The heart uses small cells known as fibroblasts to maintain its integrity ...